Liver Diseases  >>  NGC-capecitabine (PCS6422)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NGC-capecitabine (PCS6422) / Processa Pharma
NCT00319683: A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Terminated
1/2
US, RoW
ADH300004
Adherex Technologies, Inc.
Hepatocellular Carcinoma
 
 

Download Options